In hypertension, evening vs. morning dosing of antihypertensive drugs did not differ for major CV outcomes at 5.2 y.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36745893.
- Also identified by DOI 10.7326/J22-0116.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mackenzie IS, Rogers A, Poulter NR, et al. <b>Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial.</b> Lancet. 2022;400:1417-25. 36240838.
Medical subject headings
- Antihypertensive Agents
- Hypertension